Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 1 institution in 1 country.
Raúl Villanueva-RomeroDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Alicia Cabrera-MartínDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Emigdio Álvarez-CorralesDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Mar CarriónDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Selene Pérez-GarcíaDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0002-4500-8132
Amalia LamanaDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0001-8779-5034
David Castro-VázquezDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0003-2446-5075
Carmen MartínezDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0003-3541-0571
Rosa P GomarizDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0003-2839-1923
Irene Gutiérrez-CañasDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0003-0678-3619
Yasmina JuarranzDepartamento de Biología Celular, Facultad de Biología y Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0001-5886-8273
Universidad Complutense de Madrid · ES
Funding
Instituto de Salud Carlos III PI17/00027Instituto de Salud Carlos III PI20/00078Instituto de Salud Carlos III RD16/0012/0008
6 · The paper itself
Abstract
Naїve CD4
Indexed as
Th17 CellsVasoactive Intestinal PeptideCells, CulturedHumansLeukocyte Common AntigensReceptors, Vasoactive Intestinal Peptide, Type IIRNA, MessengerLeukocyte Common AntigensReceptors, Vasoactive Intestinal Peptide, Type IIRNA, MessengerVasoactive Intestinal PeptideCD4+CD45RA+ cellsnaїve Th cellsVasoactive intestinal peptideVPAC receptors
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.